Question-and-Answer SessionPriya SinghalExecutive VP & Head of Development Yes, we've been very excited to create the new Biogen. And I'm really pleased because I think we are well on our way. And I'll start with the fact that from a commercial perspective, the Alzheimer's launch, we are seeing some inflection points in the LEQEMBI launch. This is important because we just got approval for subcutaneous maintenance, which we think is a very important option for patients. And we've also begun our rolling subm ...